What’s the current market cap for BrightSpring Health Services stock?

BrightSpring Health Services (BTSG) has a market cap of $13bn as of June 11, 2026.

What is the P/E ratio for BrightSpring Health Services stock?

The price to earnings (P/E) ratio for BrightSpring Health Services (BTSG) stock is 43.43 as of June 11, 2026.

Does BrightSpring Health Services stock pay dividends?

No, BrightSpring Health Services (BTSG) stock does not pay dividends to its shareholders as of June 11, 2026.

When is the next BrightSpring Health Services dividend payment date?

BrightSpring Health Services (BTSG) stock does not pay dividends to its shareholders.

What is the beta indicator for BrightSpring Health Services?

BrightSpring Health Services (BTSG) has a beta rating of 1.87. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy BrightSpring Health Services stock | $BTSG Share Price

13:30

15:10

16:45

18:25

20:00

About BrightSpring Health Services

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

Ticker

$BTSG

Sector

Health

Primary listing

NASDAQ

Employees

23,500

Headquarters

Louisville, United States

Website

www.brightspringhealth.com

BTSG Metrics

BasicAdvanced

$13bn

43.43

$1.40

1.87

What the Analysts think about BTSG

Analyst ratings (Buy, Hold, Sell) for BrightSpring Health Services stock.

Bulls say / Bears say

Strong Q1 2026 results, with net revenue up 25.6% to $3.614 billion and Adjusted EBITDA up 44.8% year-over-year, reflecting strong pricing power and benefits of scale.

Significant deleveraging, as pro forma leverage fell to 2.27x at March 31, 2026 from 4.16x at December 31, 2024, leading to greater balance sheet flexibility and lower interest costs.

Pharmacy Solutions saw 46% year-over-year EBITDA growth in Q1 2026, fueled by a 27% increase in revenue per script—demonstrating expanding margins in the company’s primary segment.

Prescription volumes decreased by 1% year-over-year in both Q4 2025 and Q1 2026, indicating that growth relied more on price hikes than on organic volume gains, and highlighting potential exposure to pressure from payer reimbursement.

Net interest expense was $38.6 million in Q1 2026, which remains high compared to operating income of $121 million; even with deleveraging, continued high financing costs might limit profits if interest rates stay elevated.

Pharmacy Solutions contributed nearly 88% of Q1 2026 revenue, making BrightSpring highly dependent on its core pharmacy operations and exposed to regulatory shifts or pricing competition.

Data summarised monthly by Lightyear AI. Last updated on 25 May 2026.

BTSG Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

BTSG Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BTSG

Capital at risk

Market closed

Upcoming events

No upcoming events